Advertisement
UK markets open in 5 hours
  • NIKKEI 225

    38,151.00
    -123.05 (-0.32%)
     
  • HANG SENG

    17,871.90
    +108.87 (+0.61%)
     
  • CRUDE OIL

    79.17
    +0.17 (+0.22%)
     
  • GOLD FUTURES

    2,333.00
    +22.00 (+0.95%)
     
  • DOW

    37,903.29
    +87.37 (+0.23%)
     
  • Bitcoin GBP

    45,580.55
    -2,283.83 (-4.77%)
     
  • CMC Crypto 200

    1,252.94
    -86.13 (-6.44%)
     
  • NASDAQ Composite

    15,605.48
    -52.34 (-0.33%)
     
  • UK FTSE All Share

    4,418.60
    -11.65 (-0.26%)
     

Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.

While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.

Why Investors Should Pay Attention to This Value Stock

Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks.

ADVERTISEMENT

GE HealthCare Technologies (GEHC)

Chicago, IL-based GE HealthCare Technologies Inc. or GE HealthCare is one of the leading providers of medical technology, pharmaceutical diagnostics, and digital solutions with focus on precision care. The company was formed on Jan 3, 2023, following a spin-off by its parent company — the General Electric Company.

GEHC boasts a Value Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Shares of GE HealthCare Technologies are trading at a forward earnings multiple of 19.1X, as well as a PEG Ratio of 2.7, a Price/Cash Flow ratio of 15.6X, and a Price/Sales ratio of 1.9X.

A company's earnings performance is important for value investors as well. For fiscal 2024, four analysts revised their earnings estimate higher in the last 60 days for GEHC, while the Zacks Consensus Estimate has increased $0.06 to $4.30 per share. GEHC also holds an average earnings surprise of 9%.

With strong valuation and earnings metrics, a good Zacks Rank, and top-tier Value and VGM Style Scores, investors should strongly think about adding GEHC to their portfolios.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research